Concepedia

Publication | Open Access

Use of Myeloperoxidase for Risk Stratification in Acute Heart Failure

DOIFull Paper Access

120

Citations

35

References

2010

Year

Tobias Reichlin, Thenral Socrates, Patrick Egli, Mihael Potocki, Tobias Breidthardt, Nisha Arenja, Markus Noveanu, M. Reiter, Raphael Twerenbold, Nora Schaub,
Clinical Chemistry

Abstract

MPO is an independent predictor of 1-year mortality in AHF, is additive to BNP, and could be helpful in identifying patients with a favorable prognosis despite increased BNP concentrations.

References

YearCitations

Page 1